Press Release Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody 4 November 2025
Press Release Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance 4 November 2025
Press Release Douglas Elliman Inc. Appoints Renowned Attorney and Prominent Real Estate Investor and Developer Perry Weitz to Board of Directors 4 November 2025
Press Release Object First Announces 291% Year-Over-Year Increase in Global Bookings in Q3 2025 4 November 2025
Press Release TELEO Capital Closes Oversubscribed TELEO Capital II at $350 Million Hard Cap 4 November 2025
Press Release Michael Johnson, JD, Returns to Kleinfelder’s Leadership Team as National Power Market Manager 4 November 2025
Press Release Walgreens Launches Enhanced Respiratory Index to Track Flu and COVID-19 Hotspots 4 November 2025
Press Release P0 Security Extends Its Multi-Cloud Access Management for Users, NHIs and Agents, to Cover On-Prem Production Environments for Hybrid Enterprise 4 November 2025
